SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Aurobindo Pharma
Aurobindo Pharma
BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 24, 17:00
1118.35
4.85 (0.44%)
VOLUME 102,059
LIVE
NSE
Nov 24, 17:00
1117.50
5.5 (0.49%)
VOLUME 997,935
News on Aurobindo Pharma
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Aurobindo Pharma: Board meeting on Nov 25, 2014

5.14 pm | 21 Nov 2014 |  Source: Moneycontrol.com

Aurobindo Pharma has informed that a meeting of the Board of Directors of the Company will be held on November 25, 2014, to consider raising of funds ...

Buy Dr Reddy's, Aurobindo Pharma: Sudarshan Sukhani 

10.57 am | 20 Nov 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Dr Reddy's Laboratories and Aurobindo Pharma....

Do not short Nifty today; buy Wipro, ICICI Bank: Sukhani 

9.58 am | 20 Nov 2014 |  Source: CNBC-TV18

For Bank Nifty our stop loss was 17500, that it still holds so you hold on to your positions, says Sukhani....

Stay invested in Aurobindo Pharma: Hemen Kapadia 

3.52 pm | 13 Nov 2014 |  Source: CNBC-TV18

Hemen Kapadia, VP at KR Choksey Securities is of the view that one may hold Aurobindo Pharma....

Aurobindo Pharma up 4%; US arm highest bidder to buy Natrol

10.54 am | 12 Nov 2014 |  Source: Moneycontrol.com

The acquisition, however, is subject to final approval by the US Court and other statutory approvals as may be required, including any termination of ...

Aurobindo to buy US nutritional supplements maker for $133m

10.54 am | 12 Nov 2014 |  Source: Reuters

Aurobindo said the deal with Chatsworth, California-based Natrol, which sells vitamins and supplements as well as diet and weight management products,...

Aurobindo Pharma USA emerges as best bidder to acquire Natrol

10.08 am | 12 Nov 2014 |  Source: Moneycontrol.com

Aurobindo Pharma's 100% subsidiary, Aurobindo Pharma USA Inc. emerged as the highest bidder for acquisition of nutritional supplement maker, Natrol In...

Is Sun Pharma expensive at current valuations? 

4.20 pm | 11 Nov 2014 |  Source: CNBC-TV18

Purely from a short-term point of view there might not be too much of significant run up but purely on a fundamental basis Sun Pharma looks fairly str...

Sun Pharma a must in core portfolio: Experts 

3.38 pm | 11 Nov 2014 |  Source: CNBC-TV18

Market experts Nipun Mehta and Dilip Bhatdo see no negatives for Sun Pharma if the Ranbaxy deal goes through....

Aurobindo Pharma at record high, up 4% on Q2 performance

1.49 pm | 07 Nov 2014 |  Source: Moneycontrol.com

Consolidated revenue grew by 50.5 percent to Rs 2,881 crore in the quarter ended September 2014 compared to Rs 1,914 crore in the same quarter last ye...

Aurobindo Pharma Q2 net up 58% to Rs 372 cr on US generics

12.16 pm | 07 Nov 2014 |  Source: Moneycontrol.com

"The quarterly performance has been satisfactory mainly on account of overall growth led by US Generics. Our business deliveries in Europe as well as ...

Bullish on mkt; buy pvt banks, short Hindalco: CK Narayan 

9.37 am | 07 Nov 2014 |  Source: CNBC-TV18

CK Narayan of Growth Avenues says it has become a very stock specific market. He is very bullish on private banks like Kotak Mahindra Bank and Axis Ba...

Mkt amid V-shaped rally; further correction seen: Sukhani 

4.56 pm | 03 Nov 2014 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Sudararshan Sukhani of s2analytics.com shares his views on his favourite picks right now....

Prefer Aurobindo Pharma, Havells, Adani Ent: Sukhani 

2.46 pm | 03 Nov 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com reommends buying Aurobindo Pharma, Havells India and Adani Enterprises....

Tata Motors, Hero, TVS Motor to get astro support: Gupta

11.46 am | 29 Oct 2014 |  Source: Moneycontrol.com

Auto stocks like Tata Motors, Hero Motocorp, M&M, TVS Motor and Eicher Motors will be getting astrological support, says Satish Gupta of Astrostocktip...

Buy Aurobindo Pharma on dips: Sudarshan Sukhani 

4.28 pm | 22 Oct 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Aurobindo Pharma on dips....

Prefer Axis Bank, Wipro, Divis Labs: Phani Sekhar 

4.24 pm | 22 Oct 2014 |  Source: CNBC-TV18

P Phani Sekhar, Fund Manager, PMS at Angel Broking is of the view that one may prefer Divis Labs, Wipro, Hindustan Media Ventures, Indiabulls Housing ...

Buy Aurobindo Pharma, RIL, Tata Chemicals: Sukhani 

3.27 pm | 22 Oct 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Aurobindo Pharma, Tata Chemicals and Reliance Industries....

Buy Dabur, Arvind, REC, Aurobindo Pharma: Manav Chopra 

1.09 pm | 21 Oct 2014 |  Source: CNBC-TV18

Manav Chopra of Nirmal Bang recommends buying Aurobindo Pharma for a target price of Rs 985 and Rural Electrification Corporation for a target price o...

Buy Arvind, Aurobindo Pharma; sell Crompton: Vishal Malkan 

1.02 pm | 21 Oct 2014 |  Source: CNBC-TV18

Vishal B Malkan of malkansview.com recommends selling Reliance Capital with a target of Rs 420 and Crompton Greaves with a target of Rs 175....

1 2 3 4 5
Quick Links for Aurobindo Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.